Geramizadeh Bita, Safavi Fatemeh
Department of Pathology, Medical School of Shiraz University, Shiraz University of Medical Sciences, Shiraz, Iran.
Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Clin Pathol. 2021 Jul 2;14:2632010X211028209. doi: 10.1177/2632010X211028209. eCollection 2021 Jan-Dec.
Solitary fibrous tumor (SFT) is a fibroblastic tumor that has been originally reported as a pleural tumor but now has been defined as a tumor that can be seen everywhere in the human body. Histopathologically, many of the fibroblastic tumors can mimic SFT, and immunohistochemistry is necessary for differential diagnosis. Several markers have been used, and recently, STAT6 has been introduced as a diagnostic marker. No research study has been reported from Iran.
In this report, we are trying to introduce our experience about the clinicopathologic findings of 35 cases of SFT during the last 10 years from our center with an emphasis on the diagnostic role of STAT6 in this tumor.
During the last 10 years, we confirmed the diagnosis of 35 cases of SFT in the pathology archives of Shiraz University of Medical Sciences. These 35 cases were considered as cases. All the clinicopathologic findings were also extracted from the clinical charts of the patients. To evaluate the diagnostic role of STAT6, another 35 cases of spindle cell tumors were also extracted from the pathology archives as mimickers of SFT. STAT6 was stained in all of the 70 cases and controls.
Our experience showed that SFT is more common in middle-aged men with a wide age range, although it is very rare in children. It can be present in every location with a wide size range from less than 1 cm to more than 15 cm. The presence of abnormal staghorn vessels is one of the main diagnostic histopathologic characteristics. STAT6 showed a sensitivity and specificity of 91% and 86% in the diagnosis of SFT. Other markers such as CD99, CD34, and BCL2 have also been considered useful in the differential diagnosis of this tumor, although the diagnostic accuracy seems to be lower than STAT6. High mitosis, presence of necrosis, and atypia are important criteria for predicting malignant and aggressive behavior in SFT. Among 35 cases in our study, 17% showed malignant behavior as recurrent or metastatic tumors.
Solitary fibrous tumor is a common soft tissue tumor that can be seen everywhere and needs careful histopathologic and immunohistochemical evaluation for the correct diagnosis and prediction of aggressive or benign behavior.
孤立性纤维瘤(SFT)是一种成纤维细胞性肿瘤,最初被报道为胸膜肿瘤,但现在被定义为可在人体任何部位出现的肿瘤。在组织病理学上,许多成纤维细胞性肿瘤可模仿SFT,免疫组织化学对于鉴别诊断是必要的。已经使用了多种标志物,最近,STAT6被引入作为一种诊断标志物。伊朗尚未有相关研究报道。
在本报告中,我们试图介绍我们中心过去10年中35例SFT的临床病理特征方面的经验,重点是STAT6在该肿瘤中的诊断作用。
在过去10年中,我们在设拉子医科大学的病理档案中确诊了35例SFT病例。这35例被视为研究病例。所有临床病理特征也从患者的临床病历中提取。为了评估STAT6的诊断作用,还从病理档案中提取了另外35例梭形细胞瘤作为SFT的模仿者。对所有70例病例和对照进行STAT6染色。
我们的经验表明,SFT在年龄范围广泛的中年男性中更常见,尽管在儿童中非常罕见。它可出现在任何部位,大小范围从小于1厘米到超过15厘米。异常鹿角状血管的存在是主要的诊断性组织病理学特征之一。STAT6在SFT诊断中的敏感性和特异性分别为91%和86%。其他标志物如CD99、CD34和BCL2在该肿瘤的鉴别诊断中也被认为是有用的,尽管诊断准确性似乎低于STAT6。高有丝分裂率、坏死的存在和异型性是预测SFT恶性和侵袭性行为的重要标准。在我们研究的35例病例中,17%表现为复发性或转移性肿瘤的恶性行为。
孤立性纤维瘤是一种常见的软组织肿瘤,可在任何部位出现,需要仔细的组织病理学和免疫组织化学评估以正确诊断并预测侵袭性或良性行为。